ALLUCENT CONSULTING
Live / Applied — Fourth extension granted (statement of use) (as of 22 Sept 2025)
What this means for you
Not registered yet, but its 17 Mar 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97318068
- Mark type
- Stylized text
- Filed
- 17 Mar 2022
- Published for opposition
- 01 Aug 2023
- Attorney of record
- Becky Troutman
Goods and services
- Class 035 — Advertising and business services: Data management, namely, abstraction services in the nature of extracting and summarizing information from clinical trial records and collection of medical data from clinical tests and records for business purposes; Market research and business marketing consulting services in the pharmaceutical, biotechnology, medical device, and diagnostics industries; Data management, namely, the management for others of databases of patient health data
- Class 041 — Education and entertainment services: Training and development in the field of conducting clinical trials, namely, conducting tutorials, seminars and workshops in the field of clinical trials; training in the field of computer software support, namely, conducting tutorials, seminars and workshops in the field of software support
- Class 042 — Scientific and technological services: Cloud computing featuring software that allows users to collect, review, analyze and report on clinical research; technical support services, namely, installation and remote administration of software, and troubleshooting of software problems and hosted software applications, all for use in connection with medical research and product regulatory approval, environmental health, health care, and in relation to the design, research, development, and testing of new medical products and devices; cloud computing featuring software for providing telehealth, telemedicine, remote care and virtual health care services to patients; cloud computing featuring software that allows users to collect, track, retrieve, validate, summarize, statistically analyze and present data used in the areas of medical research and product regulatory approval, environmental health, health care, and in relation to the design, research, development, and testing of new medical products and devices; Cloud computing featuring software to aggregate, integrate, transfer and manage data generated from home health and remote monitoring devices and applications and health-related smart-phone applications; Cloud computing featuring software that provides integrated workflows, analytics, visualizations, and reporting features to deliver, process, analyze, elevate, and display patient-generated health data; Cloud computing featuring software that integrates remotely collected health data into databases, systems, platforms, applications, and software that inform clinical research, remote monitoring, and care management; technical consulting services, namely, evaluating the safety of pharmaceutical, medical, cosmetic and consumer devices and products in clinical development or in commercial production; Consulting services for others in the fields of design, planning, implementation and project management of clinical trials; Scientific analysis of statistical and qualitative data relating to clinical trials for pharmaceuticals, biotechnology, medical devices and diagnostics for scientific research and for the development of pharmaceutical, biotechnology, medical device and diagnostic products and methods of use of such devices and products
- Class 045 — Legal and security services: Development of regulatory compliance strategies in the field of medical research, namely, regulatory compliance consulting in the field of drug, biologic, cosmetic and medical device development
Owner
- Clinical Services Corporate Operations, Inc., Cary, NC, US
- Clinical Services Corporate Operations, Inc., Waltham, MA, US
Prosecution history
- 23 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 22 Sept 2025 — SOU EXTENSION 4 GRANTED
- 22 Sept 2025 — SOU EXTENSION 4 FILED
- 22 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 06 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Mar 2025 — SOU EXTENSION 3 GRANTED
- 05 Mar 2025 — SOU EXTENSION 3 FILED
- 05 Mar 2025 — SOU TEAS EXTENSION RECEIVED
- 25 Sept 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Sept 2024 — SOU EXTENSION 2 GRANTED
- 25 Sept 2024 — SOU EXTENSION 2 FILED
- 25 Sept 2024 — SOU TEAS EXTENSION RECEIVED
- 11 Apr 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 11 Apr 2024 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 11 Apr 2024 — TEAS CHANGE OF OWNER ADDRESS RECEIVED